Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000459918 | SCV000553351 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313181 | SCV000849251 | benign | Inborn genetic diseases | 2017-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000459918 | SCV001783914 | likely benign | not provided | 2021-03-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003457687 | SCV004178000 | likely benign | Developmental and epileptic encephalopathy, 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005407127 | SCV006071388 | uncertain significance | not specified | 2025-03-25 | criteria provided, single submitter | clinical testing | Variant summary: SZT2 c.8006C>G (p.Thr2669Ser) results in a conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00043 in 247450 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in SZT2 causing Early Infantile Epileptic Encephalopathy 18, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.8006C>G in individuals affected with Early Infantile Epileptic Encephalopathy 18 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 411936). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Centre de Biologie Pathologie Génétique, |
RCV001252126 | SCV001427876 | uncertain significance | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing |